Transdermal glyceryl trinitrate (nitroglycerin) in healthy persons
acute effects on skin temperature and hemodynamic orthostatic response
Keywords:
Transdermal Glyceryl Trinitrate (GTN), Skin temperature, Orthostatic reaction, Healthy personsAbstract
In order to find an explanation for individual reactions to transdermal glyceryl trinitrate (GTN) we studied the skin temperature and hemodynamic reactions in 63 healthy persons. The data were obtained before and after the application of GTN and Glycerin (GL) placebo patches, during one hour. The skin temperature was measured on both forearms, the local (left sided) and systemic (right sided) reaction on GTN was related to the skin fold and the calculated body fat content. The bilateral rise of skin temperature and its duration was higher and longer in obese than in lean persons mainly in obese women. The UV induced thermo and the later photothermoreaction (Erythema) was reduced on the left forearm after the application of GTN and GL patches. The observed hemodynamic GTN effect confirmed known postural reactions, such as decreased arterial pressure (ΔmAP = -2.9%), increased heart rate (ΔHR = +7,4%) and QTc prolongation (ΔQTc = +4,9%) in upright position. An adverse drug effect with increased mean blood pressure (ΔmAP = +12%) and increased heart rate (ΔHR = + 10.4%) mainly in supine position was observed in 11 % of the participants, but only in men. Such a reaction was already described by Murell, 1879. Individual GTN effects were analyzed and related to habits and family history. In male smokers and in persons with hypertensive and diabetic close relatives, the hypotensive GTN effect was accentuated in supine position. In the upright position the group with hypertensives in the family presented a moderate hypotensive reaction without secondary tachycardia and the smokers presented only a slightly increased heart rate. Our observations suggest that individual reactions to transdermal glyceryl trinitrate (GTN) with its active component nitric oxide (NO) depends on physiological conditions, related to endogenous vasoactive substances, mainly the interaction with EDRF (the endogenous NO) and the activity of the Renin-Angiotensin System.
Downloads
References
PARRAT, J.R. - Nitroglycerin - the first one hundred years: new facts about an old drug (review). J. Pharm. Pharmacol. 31:801-809, 1979.
KATZUNG, B.G. & CHATTERJEE K. - Vasodilators and treatment of angina pectoris. In Bertram G. Katzung (Editor): Basic and Clinical Pharmacology Ed. 4. Rio de Janeiro, Prentice - Hall International, p. 149, 1989.
KALTENBACH, M & SCHNEIDER, W. - Fortbestehen der antianginoesen Wirksamkeit unter chronischer Nitrattherapie trotz Aufhebung haemodynamischer Teileffekte. Dtsch. Med. Wschr. 111:383-386, 1986.
FLAHERTY, J.T. - Clinical relevance of Nitrate hemodynamic attenuation. Am. Heart J. 112(1): 216-220, 1986.
BASSENGE, E.D. & STEWART, D.J. - Effects of nitrates in various vascular sections and regions. Z. Kardiol. 75(3): 1 - 7, 1986.
PARKER, J.O. - Efficacy of nitroglycerin patches: fact or fancy? Ann. Int. Med. 102(4):548-549, 1985.
ODENTHAL, H.J., WIECHMANN, H.W., JOSEPHS, W. & LENGA, P. - Transdermale Nitroglycerinsysteme mit kontinuierlicher und diskontinuierlicher Substanzfreisetzung. Vergleich anti-ischaemischer and haemodynamischer akut and Langzeit-Wirkung. Dtsch. Med. Wschr. 116:241-247, 1991.
CARASH, B. & SCHEIDT, S.S. - The controversy over transdermal nitroglycerin: an update. Am. Heart J. 112(1):207-215, 1985.
MUELLER, P. IMHOF, P.R., BURKART, F., CHU, L.C. & GÉRADIN, A. - Human pharmacological studies of a new transdermal system containing nitroglycerin. Eur. J. Clin. Pharmacol. 22: 473-480, 1982.
BEHNKE, A.R. - The relation of lean body weight to metabolism and some consequent systematizations. Ann. N.Y. Acad. Sci. 56:1095-1142, 1953.
BAZETT, H.C. - An analysis of the time relations of electrocardiograms. Heart 7:353-370, 1920.
DIXON, W.J. - BMDP-statistical software Berkeley University of California Press, 1981.
BUSSAB, W.O. & MORETTI, P.A. - Estatística Básica. 3a. ed. São Paulo, Atual Editora, 1986.
WINER, B.J. - Statistical principles in experimental design Ed. 2. New York, McGraw-Hill, p. 907, 1971.
MASON, D.T. & BRAUNWALD, E. - The effects of nitroglycerin in amylnitrite on arteriolar and venous tone in the human forearm. Circulation 32:755-766, 1965.
PIZZULLI, L., NITSCH, J. & LUEDERITZ, B. - Hemmung der Heparin-Wirkung durch Glyceroltrinitrat. Dtsch. Med. Wschr. 113:1837-1840, 1988.
PIZZULLI, L. , KOEHLER, U., NITSCH, J. & LUEDERITZ, B. - Arzneimittelinteraktion zwischen Glycerol-trinitrat and Heparin. Z. Kardiol. (77 suppl.) 1:83-86, 1988.
COHN, P.F. & GORLIN, R. Physiologic and clinical actions of nitroglycerin. Med. Clin. North. Am. 58:407-412, 1974.
NEEDLEMAN, P., CORR, P.B. & JOHNSON JR., E.M. - Drugs used for treatment of angina: organic nitrates. In Goodman and Gilman (Editors). The pharmacological Basis of Therapeutics Ed. 7. New York, Macmillan Publishing, 1985, p. 806-816.
CRAMPTON R. - Prominence of the left stellate ganglion in the long QT syndrome. Circulation, 59:769-778, 1979.
LEPESCHKIN E. - Vasodilatatory drugs: Nitroglycerine. In Lepeschkin E. (Editor). Modern electrocardiography Vol. 1. Baltimore, The Williams and Wilkins, 1951, p. 302-303.
MONCADA, S. , PALMA, R.M.J. & HIGGS E.A. - The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension 12(4):365-372, 1988.
BUSSMANN, W.D. - Nitratpflaster: Wirkungsdauer-Wirkungsverlust. Uberlegungen zum Wirkungsmechanismus von Nitraten. Dtsch. Med. Wschr. 114:2023-2026, 1989.
LUESCHER, Endotheliale Relaxation and Kontraktion. Dtsch. Med. Wschr. 116:747-754, 1991.
FOERSTERMAN, U. - EDRF (endothelium derived relaxing factor) der koerpereigene Nitrovasodilatador. Dtsch. Med. Wschr. 113:1215-1 217, 1988.
CARVALHO, M.H.C., SCIVOLETTO R. , FORTES, Z.B. & NIGRO, D. - The role of endothelium in vascular reactivity. Brazilian J. Med. Biol. Res. 22:533:545, 1989.
LEVIN, R.D., WEKSLER, B.B. & JAFFÉ E.A. - Nitroglycerin induces production of prostacyclin by human endothelial cells. Clin. Res. 28:417A, 1980.
WILLIAMS, G.H. & DLUHY R.G. - Diseases of the adrenal cortex. In Wilson, J.D. et al. (Editors). Harrison's Principles of internal medicine 12 ed., New York, São Paulo, McGraw Hill, 1991, p. 1716.
LAWSON, D.L., NICHOLS, W.W., MEHTA, P. & MEHTA, J.L. - Captopril induced versal of nitroglycerin tolerance: role of sulphydryl groups versus ACE-inhibitory activity. J. Cardiovascular Pharmacology 17:411-418, 1991.
GOLDBERG, N.D. - Guanylatocyclase contem sulphydryl groups. Ann. Rev. Biochem. 46:823-896, 1977.
WILLIAMS, G.H. - Hypertensive vascular disease. In Wilson, J.D. et al. (Editors). Harrison's Principles of internal medicine 12 ed., New York, São Paulo, McGraw Hill, 1991, p. 1005.
BOECKH HAEBISCH, E.M.A. - Pharmacological Trial of a concentrated crude extract of Stevia rebaudiana (Bert) Bertoni in healthy volunteers. Arq. Biol. Tecnol. 35(2):299-314, 1992.
SCHMIDT, R.F. & THEWS, G. - Human Physiology. Tests of orthostatic response 20 Ed.. Berlin, Heidelberg, New York, Springer-Verlag, 1983, p. 442.
REYNEN, K. - Nitrate. Dtsch Med. Wschr. 118:1532-1539, 1993.
